Prevention of ventilator-associated pneumonia with inhaled antibiotics  

作　　者：Stephan Ehrmann Jie Li 

机构地区：[1]Intensive Care Medicine,INSERM CIC 1415,CRICS-TriggerSep FCRIN research network,University Hospital Center in Tours,Tours 37044,France [2]Respiratory Pathology Research Center,National Institute of Health and Medical Research,Tours 37000,France [3]Department of Cardiopulmonary Sciences,Division of Respiratory Care,Rush University,Chicago 60612,USA

出　　处：《World Journal of Emergency Medicine》2024年第3期165-168,共4页世界急诊医学杂志（英文）

摘　　要：The direct delivery of inhaled antibiotics to the respiratory tract has been a subject of enduring interest among medical practitioners and researchers due to the associated favorable pharmacokinetics.This interest has been particularly pronounced in the context of critically illpatients,wherehealthcare-associatedpulmonary infections represent a significant challenge,driving continued exploration of inhaled antibiotics for intubated patients.Recent high-level evidence has shown a very promising application in the field of ventilator-associated pneumonia (VAP) prevention.^([1]).

关 键 词：PNEUMONIA VENTILATOR RESPIRATORY 

分 类 号：R563.1[医药卫生—呼吸系统]